CV protection by SGLT2 inhibition: Potential mechanisms for benefit
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Asian CDF: Addressing Cardiovascular Outcomes in T2DM: Exploring Novel StrategiesThe EMPA REG Outcome trial: The challenge for cardiologists in managing T2DM
David Fitchett, MD